Member Info for scotlouie

https://www.tradingview.com/x/x4sB9RRU/

close above 139p with decent volume should indicate a breakout on the charts and SP should move up fast

its going to be a busy end to the year! ovarian news, FDA approval, lab contract and even a partnership to finish it off.

ok ok.... all thats made up but lets face it, all of that could actually happen and each one of those statements could have a big impact on SP. until news comes then nothing much we can do other than wait.... and believe in the story and watch it unfold!

bring on the santa rally ;)

ive been researching WEBIS and have a question for the board. within californias 2022 ballot, a ballot has been put forward to legalise betting on american indian land. my question is.... is calexpo racetrace on american indian land? and will they benefit if the california law changes to support betting on indian lands?

https://investegate.co.uk/allergy-therapeutics--agy-/rns/allergy-announces-positive-g309-results/202110250700130234Q/

theres a RNS released this morning not showing on LSE

https://www.tradingview.com/x/Bw2z8vjG/

forgot chart in last post

cup and handle chart pattern starting to form on the charts. rounded bottom suggests another retest on the 144p area soon. once broke through then its breakout territory.

daily chart is based without news obviously. when we do receive FDA/ lab news then pretty sure 144p will be blown away.

all looking good while we continue building higher lows and higher highs in this current uptrend.

tec, trinty delta have a research paper out on AGL. worth a read if your still researching the company.

https://www.trinitydelta.org/

bit of an over reaction from the POLX related rejected FDA news. i get the feeling after the huge drop on POLX it has maybe scared a lot who has been sitting on a big profit to reduce their holding and derisk as we all know our own FDA approval news isnt set in stone nor should it be looked at as a guarantee. i think todays sp is nothing more than an over reaction and a derisk from investors. id like to see sp bouncing back before the week finishes and get back into the 1.20-1.30 range. we'll see. havent sold any and actually trying to raid the piggy bank for a top up tomorrow if it stays low.

seems to be good questions and answers to the Q&A after results. all positive and things looking good.

i know AGL have always said they want to grow the buisness and have the backing of the mahor shareholders to turn the company into a multi billion $ company but i just cant see why there wont be a bidding war or some serious offers to takeover AGL before they get able to become a big player. surely it would be in the best interests of the bigger comps to completely own the parsortix IP.

either way its good for sshareholders i guess. just sit back and watch the investment grow. one way or another i only see an upwards direction on the long term.

gawd, angle wont need to go through the lengthy process again. after fda approval has been granted for the de novo request the following applications can be made through 510k and costs far less time and money as long as the data is shown to capture/harvest different cancer types. angle have tried to go through the route of a blanket cancer type fda application but was ill advised by advisors. then changed to a specific cancer type from conversations and feedback from the FDA . thus is where we are now awaiting approval

another excellent bit of news supporting the fact that angle will soon be dominating in their field.

more pieces of the jigsaw puzzle being put together.

soon FDA approval then as said in the old pinky and the brain tv show.... "try to take over the world"

were here till the end, hic... here for 9 years whats another 9 eh!! ;)

i don't think anyone has doubts where AGL is going other than yourself jake.

and if you look at the chart since the start of the year you can see a rise from 40p. no sp goes up in a straight line it rises and goes through consolidation periods, then moves onto next step. we are still very much in an uptrend.

a jam stock is a garbage stock that is pumped and has a high spike up then usually crashes back down next few days. please explain any examples where AGL is compared to a jam stock. i dont think you'll find one. its a slow burner and will have its ups and downs but most definitely is nothing like a jam stock.

i wouldn't be surprised to see a late pm rise into close. big trades coming in yesterday and now today. looks like the big orders are being filled in the background and mm's keeping a lid on price movement until orders are filled. one way to look at it is someone is happy to accumulate a big amount of shares at current sp.

follow the money as the saying goes

good start to the week. lets see if the momentum continues pushing us closer to that 52 week high of 141p. would be a great starting point of 1.4-1.5 pre fda news. and hold at that level.

exciting times ahead.

struggling to get a quote for a while. had to set a limit buy for a top up. lools like sellers may have left the building and mms might start the rise soon

and not forgetting about news thats should come in next few weeks regarding the ovarian trails.

"The HyCEAD molecular analysis of the Parsortix processed samples is expected to take place in Q3 2021 with the Study reporting headline results in Q4 2021."

we are currently nearing the end of Q3 of 2021 so i expect the samples being processed now. with results in coming weeks. possible a very busy few weeks with the FDA approval news, ovarian trails, throw in a few lab contracts and partnerships after FDA then by year end SP should be looking a great deal better than todays SP.

late trade of half a mill popping up. wonder if the seller has now finished and thats the last of the iceberg.

ah i forgot about that. i prob seen it also and totally forgot about it until i was scanning thier website.

and to reply to your positive spin on cnel... i dont actually have a positive thing to say about cnel. and ill be surprised if i ever see a profit on my investment or even if they do actually return to market. sept 2022 is the deadline to sort their **** out and return to market. if not then its bye bye capital.

it is very worrying how long its taking them to respond with the correct info to HKex. you would think that would be priority number 1.... but cnel bod's doesnt seem to be moving quickly on things.